UCB - Fremdkapital





Fremdkapital Veränderung Datum
Alcon AG USD 4.16B 434M 2026-03
Almirall EUR 303.77M 21.04M 2026-06
argenx SE USD 36M 432K 2026-06
AstraZeneca USD 26.01B 46M 2026-06
Bayer EUR 30.68B 1.15B 2026-03
Genmab DKK 5.14B 5.01B 2025-12
GlaxoSmithKline GBP 13.95B 65M 2026-06
GRIFOLS EUR 9.08B 612M 2026-03
Hikma Pharmaceutical USD 1.49B 692M 2025-12
Lakefront Biotherapeutics EUR 4.85M 335K 2026-03
Lonza CHF 3.88B 323M 2025-12
Merck EUR 10.8B 72M 2026-03
Novartis USD 37.49B 42M 2026-06
Orion EUR 103.4M 7.2M 2026-06
Recordati EUR 1.76B 373.2M 2026-03
Roche Holding CHF 25.22B 2.21B 2026-06
Sanofi EUR 13.84B 1.88B 2026-03
UCB EUR 2.18B 634M 2025-12
Unibail Rodamco EUR 21.57B 88M 2025-12